What is the Return on Assets (ROA) of Resmed this year?
The Return on Assets (ROA) of Resmed is 0.17 undefined this year.
Resmed ROA 2025
Resmed ROA
0.17
Ticker
RMD
ISIN
US7611521078
WKN
895878
In 2025, Resmed's return on assets (ROA) was 0.17, a 28.9% increase from the 0.13 ROA in the previous year.
Resmed Aktienanalyse
What does Resmed do?
ResMed Inc. is a global leading provider of medical devices for the treatment of sleep disorders and respiratory diseases. The company was founded in Australia by Peter Farrell, a former employee of the University of New South Wales, in 1989. Today, ResMed is headquartered in San Diego, California, and employs over 7,500 people worldwide. Business model: ResMed's business model is based on providing medical products and solutions for the treatment of sleep apnea and other respiratory diseases. The company develops and distributes masks, devices, and accessories that help patients breathe better and achieve restful sleep. ResMed also offers cloud-based software solutions and services to assist doctors and sleep labs in diagnosing and monitoring patients. Products and divisions: ResMed's product range can be divided into four main divisions: Sleep & Respiratory Care, Software as a Service (SaaS), Technologies, and Dental Solutions. Sleep & Respiratory Care: In this division, ResMed offers a wide range of masks, devices, and accessories for the treatment of sleep apnea and other respiratory diseases. The most well-known products include the AirSense and AirMini devices, equipped with Automatic Sleep Detection and AutoSet algorithm to optimize respiratory pressure. ResMed also offers a range of CPAP masks, nasal and full face masks, as well as nasal pillow masks. Software as a Service (SaaS): ResMed's cloud-based software solutions and services are offered under the brand AirView. They include diagnostic tools, patient monitoring systems, and analysis tools. AirView allows doctors to access their patients' medical data captured by ResMed devices and monitor this data in real-time. Technologies: ResMed's Technologies division focuses on the development of advanced sensors for respiratory and sleep monitoring. Products include the S+, a smart sleep tracking system that operates without direct body contact, and the Reveal-LTE, an implant for monitoring heart and respiratory rates in patients with heart failure. Dental Solutions: ResMed has also developed products for dentistry to assist patients with mild to moderate upper airway obstruction. Products include the Narval CC, a custom-made dental device for the treatment of snoring and sleep apnea, and the Tap Pap nasal pillow oral appliance, a non-invasive mouthguard. Conclusion: ResMed is a leading provider of medical devices and solutions for the treatment of sleep apnea and other respiratory diseases. The company offers innovative products and technologies that help patients breathe better and achieve restful sleep. ResMed's cloud-based software solutions enable doctors to monitor their patients' health in real-time and develop effective diagnosis and treatment strategies. With its wide range of products, innovation, and highly qualified team of scientists, engineers, and medical professionals, ResMed will continue to play an important role in the healthcare industry. Resmed ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Resmed's Return on Assets (ROA)
Resmed's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Resmed's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Resmed's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Resmed’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Resmed stock
What was the ROA of Resmed compared to the previous year?
The ROA of Resmed has increased by 28.9% compared to the previous year.
What consequences do high ROA have for investors of Resmed?
A high ROA is advantageous for investors of Resmed, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Resmed?
A low ROA can be unfavorable for investors of Resmed as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Resmed affect the company?
An increase in ROA of Resmed can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Resmed impact the company?
A reduction in the ROA of Resmed can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Resmed?
Some factors that can influence the ROA of Resmed include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Resmed important for investors?
The ROA of Resmed is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Resmed take to improve ROA?
To improve ROA, Resmed can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Resmed pay?
Over the past 12 months, Resmed paid a dividend of 2.12 USD . This corresponds to a dividend yield of about 0.74 %. For the coming 12 months, Resmed is expected to pay a dividend of 2.4 USD.
What is the dividend yield of Resmed?
The current dividend yield of Resmed is 0.74 %.
When does Resmed pay dividends?
Resmed pays a quarterly dividend. This is distributed in the months of December, March, June, September.
How secure is the dividend of Resmed?
Resmed paid dividends every year for the past 19 years.
What is the dividend of Resmed?
For the upcoming 12 months, dividends amounting to 2.4 USD are expected. This corresponds to a dividend yield of 0.84 %.
In which sector is Resmed located?
Resmed is assigned to the 'Health' sector.
Wann musste ich die Aktien von Resmed kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Resmed from 9/18/2025 amounting to 0.6 USD, you needed to have the stock in your portfolio before the ex-date on 8/14/2025.
When did Resmed pay the last dividend?
The last dividend was paid out on 9/18/2025.
What was the dividend of Resmed in the year 2024?
In the year 2024, Resmed distributed 1.92 USD as dividends.
In which currency does Resmed pay out the dividend?
The dividends of Resmed are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Resmed stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Resmed
Our stock analysis for Resmed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Resmed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
